Read More

Biomerica Receives Notice Of Patent Allowance In China For A Potential Innovative Technology That Includes An Artificial Intelligence Claim For Predicting Foods That Contain Ingredients That Cause Adverse Reactions In Patients

Patent Claims Describe a Novel System to Predict and Help Prevent Adverse Food Reactions Using Personal Medical Data   The Patent further describes Algorithms to help Determine Safety Levels of Food Ingredients,

BMEA

Read More

Biomea Fusion To Present Data From Ongoing Phase II Trial, COVALENT-111, Evaluating BMF-219 In Patients With Type 2 Diabetes At ADA 2023

New clinical data from COVALENT-111 will be unveiled during a late-breaking poster presentation at ADA's Scientific Sessions BMF-219, an orally delivered novel covalent menin inhibitor, is designed to regenerate, preserve, and reactivate healthy, insulin-producing beta cells

BMEA

Read More

These 5 High-Growth Small-Cap Stocks Surged More Than 100% In Q1: What’s Next?

The S&P 500 index, which is tracked by the SPDR S&P 500 ETF Trust (ARCA: SPY), posted a gain of 6.2% in the first quarter of 2023, while technology stocks in the Nasdaq 100 index, which is tracked by the Invesco QQQ Trust Series 1 (ARCA: QQQ), fared much better by posting a 20% increase in the quarter, also marking the third-best quarterly per

AI